Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2004

01-11-2004 | Brief Report

Alveolar echinococcosis in a patient without hepatic disturbance and with unusual humoral immune response

Authors: F. Persat, C. Pariset, B. Gottstein, J. Ninet, S. Picot

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2004

Login to get access

Excerpt

Human alveolar echinococcosis (AE) is a parasitosis caused by the larval stage of Echinococcus multilocularis, a tapeworm belonging to the family Taeniidae [1]. The adult parasites reside in fox intestines where they produce eggs released in feces. Eggs are usually ingested by rodents, the intermediate hosts of the parasite, or accidentally by humans. After the eggs hatch in the intestine, the embryos make their way to other organs, especially the liver, and develop into the larval stage. AE is a highly pathogenic and potentially fatal chronic liver infestation that is characterized by a tumor-like multivesicular, infiltrating structure [2]. Early diagnosis can improve the management and the treatment of affected patients, and it relies on complementary procedures such as clinical findings, imaging techniques, hepatic metabolic marker analysis and immunodiagnosis. Serological tests to detect AE are similar to those used for cystic echinococcosis (CE) caused by Echinococcus granulosus. These tests have recently been improved and are generally known to be more reliable for AE than for CE infection [1]. Nevertheless, we report a case of asymptomatic hepatic AE in a patient with normal liver enzymes in which serological tests resulted negative for conventional E. multilocularis antibodies. …
Literature
1.
go back to reference Zhang W, Li J, McManus DP (2003) Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev 16:18–36CrossRefPubMed Zhang W, Li J, McManus DP (2003) Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev 16:18–36CrossRefPubMed
3.
go back to reference Gottstein B, Jacquier P, Bresson-Hadni S, Eckert J (1993) Improved primary immuno-diagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus-antigen. J Clin Microbiol 31:373–376PubMed Gottstein B, Jacquier P, Bresson-Hadni S, Eckert J (1993) Improved primary immuno-diagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus-antigen. J Clin Microbiol 31:373–376PubMed
4.
go back to reference Gottstein B, Mowatt MR (1991) Sequencing and characterization of an Echinococcus multilocularis DNA probe and its use in the polymerase chain reaction (PCR). Mol Biochem Parasitol 44:183–194CrossRefPubMed Gottstein B, Mowatt MR (1991) Sequencing and characterization of an Echinococcus multilocularis DNA probe and its use in the polymerase chain reaction (PCR). Mol Biochem Parasitol 44:183–194CrossRefPubMed
5.
go back to reference Diebold Berger S, Khan H, Gottstein B, Puget E, Frossard JL, Remadi S (1997) Cytologic diagnosis of isolated pancreatic alveolar hydatid disease with immunologic and PCR analyses—a case report. Acta Cytol 41:1381–1386PubMed Diebold Berger S, Khan H, Gottstein B, Puget E, Frossard JL, Remadi S (1997) Cytologic diagnosis of isolated pancreatic alveolar hydatid disease with immunologic and PCR analyses—a case report. Acta Cytol 41:1381–1386PubMed
6.
go back to reference Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, The European Echinococcosis Registry (2003) European echinococcosis registry: human alveolar echinococcosis Europe, 1982-2000. Emerg Infect Dis 9:343–349PubMed Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, The European Echinococcosis Registry (2003) European echinococcosis registry: human alveolar echinococcosis Europe, 1982-2000. Emerg Infect Dis 9:343–349PubMed
7.
go back to reference Bartholomot B, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, Wang YH, Macpherson CNL, Craig PS (2002) Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. Am J Trop Med Hyg 66:23–29PubMed Bartholomot B, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, Wang YH, Macpherson CNL, Craig PS (2002) Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. Am J Trop Med Hyg 66:23–29PubMed
8.
go back to reference Amman R, Eckert J (1995) Clinical diagnosis and treatment of echinococcosis in humans. In: Thompson RCA, Lymbery AJ (eds) Echinococcus and hydatid disease. CAB International, Wallingford, pp 411–463 Amman R, Eckert J (1995) Clinical diagnosis and treatment of echinococcosis in humans. In: Thompson RCA, Lymbery AJ (eds) Echinococcus and hydatid disease. CAB International, Wallingford, pp 411–463
Metadata
Title
Alveolar echinococcosis in a patient without hepatic disturbance and with unusual humoral immune response
Authors
F. Persat
C. Pariset
B. Gottstein
J. Ninet
S. Picot
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2004
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-004-1227-0

Other articles of this Issue 11/2004

European Journal of Clinical Microbiology & Infectious Diseases 11/2004 Go to the issue

Announcements

November 2004

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.